Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Creatine kinase B-type (CKB), also known as brain-type creatine kinase or CK-BB, is a cytosolic enzyme encoded by the CKB gene in humans. It plays a central role in cellular energy homeostasis and is involved in several physiological and pathological processes. CKB catalyzes the reversible transfer of phosphate groups between ATP and creatine or phosphocreatine (PCr) and ADP, regenerating ATP from ADP. It is critical for tissues with high fluctuating energy demands. Beyond its metabolic function, CKB regulates adaptive thermogenesis, suppresses ferroptosis, and inhibits epithelial-mesenchymal transition (EMT). Overexpression is observed in certain cancers, and it may regulate immune cell activation/development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Creatine Kinase B-type (CKB).